Last updated on May 2017

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Cancer


Brief description of study

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Cancer

Detailed Study Description

The MR-guided ExAblate Focused Ultrasound study is being conducted to assess the safety and effectiveness of an investigational device for the treatment of prostate cancer.

The ExAblate treatment is a focal treatment where a small portion of the prostate is treated, only where the cancer is located.

The study will enroll 100 patients with intermediate risk, localized, organ confined prostate cancer. For most study patients, this study will last for up to 26 – 30 months. If you qualify for the study, you will receive the ExAblate treatment.

This clinical research study will evaluate the safety and effectiveness of ExAblate for the treatment of intermediate risk, localized, organ confined prostate cancer.

Clinical Study Identifier: TX149745

Contact Investigators or Research Sites near you

Start Over

Bianca Del Vecchio

City of Hope
Duarte, CA USA
  Connect »

Tammy Floore, BSN, MBA

University of California Los Angeles
Los Angeles, CA USA
  Connect »

Denise Haas

Stanford University School of Medicine
Stanford, CA USA
  Connect »

John Gentile

Sperling Prostate Center
Delray Beach, FL USA
  Connect »

Patti Goldberger

Brigham & Women's Hospital
Boston, MA USA
  Connect »

Christopher T Tallman, MD

Henry Ford Hospital:
Detroit, MI USA
  Connect »

Connie Sathre

Mayo Clinic
Rochester, MN USA
  Connect »

Jamie Stern

Weill Cornell Medical Center
New York, NY USA
  Connect »

Michal Wiseman

Memorial Sloan-Kettering Cancer Center
New York, NY USA
  Connect »

Amy B Smith, BA

University of Virginia
Charlottesville, VA USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.